<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37669302</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus B3 elicits a sex-specific CD8+ T cell response which protects female mice.</ArticleTitle><Pagination><StartPage>e1011465</StartPage><MedlinePgn>e1011465</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1011465</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1011465</ELocationID><Abstract><AbstractText>Sex is a significant contributor to the outcome of human infections. Males are frequently more susceptible to viral, bacterial, and fungal infections, often attributed to weaker immune responses. In contrast, a heightened immune response in females enables better pathogen elimination but leaves females more predisposed to autoimmune diseases. Unfortunately, the underlying basis for sex-specific immune responses remains poorly understood. Here, we show a sex difference in the CD8+ T cell response to an enteric virus, Coxsackievirus B3 (CVB3). We found that CVB3 induced expansion of CD8+ T cells in female mice but not in male mice. CVB3 also increased the proportion and number of CD11ahiCD62Llo CD8+ T cells in female mice, indicative of activation. This response was independent of the inoculation route and type I interferon. Using a recombinant CVB3 virus expressing a model CD8+ T cell epitope, we found that the expansion of CD8+ T cells in females is viral-specific and not due to bystander activation. Finally, the depletion of CD8+ T cells, prior to infection, led to enhanced mortality, indicating that CD8+ T cells are protective against CVB3 in female mice. These data demonstrate that CVB3 induces a CD8+ T cell response in female mice and highlight the importance of sex-specific immune responses to viral pathogens.</AbstractText><CopyrightInformation>Copyright: © 2023 Dhalech et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dhalech</LastName><ForeName>Adeeba H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Condotta</LastName><ForeName>Stephanie A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pattnaik</LastName><ForeName>Aryamav</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corn</LastName><ForeName>Caleb</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richer</LastName><ForeName>Martin J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0003-4086-4690</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 DK110216</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N92020D00005</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93022D00005</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N99020D00005</GrantID><Acronym>OF</Acronym><Agency>ORFDO NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 DK124749</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N95020D00005</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93023D00005</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018984" MajorTopicYN="N">Epitopes, T-Lymphocyte</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="Y">Interferon Type I</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018155" MajorTopicYN="Y">Orthopoxvirus</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37669302</ArticleId><ArticleId IdType="pmc">PMC10503745</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1011465</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-23-00099</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>vom Steeg LG, Klein SL. SeXX Matters in Infectious Disease Pathogenesis. PLoS Pathog. 2016;12(2):e1005374. doi: 10.1371/journal.ppat.1005374 ; PubMed Central PMCID: PMC4759457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005374</ArticleId><ArticleId IdType="pmc">PMC4759457</ArticleId><ArticleId IdType="pubmed">26891052</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 2019;41(2):239–49. Epub 2018/12/14. doi: 10.1007/s00281-018-0726-5 ; PubMed Central PMCID: PMC6373179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-018-0726-5</ArticleId><ArticleId IdType="pmc">PMC6373179</ArticleId><ArticleId IdType="pubmed">30547182</ArticleId></ArticleIdList></Reference><Reference><Citation>Condotta SA, Richer MJ. The immune battlefield: The impact of inflammatory cytokines on CD8+ T-cell immunity. PLoS Pathog. 2017;13(10):e1006618. Epub 2017/10/27. doi: 10.1371/journal.ppat.1006618 ; PubMed Central PMCID: PMC5658174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006618</ArticleId><ArticleId IdType="pmc">PMC5658174</ArticleId><ArticleId IdType="pubmed">29073270</ArticleId></ArticleIdList></Reference><Reference><Citation>Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol. 2008;8(4):247–58. Epub 2008/03/08. doi: 10.1038/nri2274 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2274</ArticleId><ArticleId IdType="pubmed">18323851</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin MD, Badovinac VP. Defining Memory CD8 T Cell. Front Immunol. 2018;9:2692. Epub 2018/12/06. doi: 10.3389/fimmu.2018.02692 ; PubMed Central PMCID: PMC6255921.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02692</ArticleId><ArticleId IdType="pmc">PMC6255921</ArticleId><ArticleId IdType="pubmed">30515169</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016. doi: 10.1038/nri.2016.90 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankaran-Walters S, Macal M, Grishina I, Nagy L, Goulart L, Coolidge K, et al.. Sex differences matter in the gut: effect on mucosal immune activation and inflammation. Biol Sex Differ. 2013;4(1):10. Epub 2013/05/09. doi: 10.1186/2042-6410-4-10 ; PubMed Central PMCID: PMC3652739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2042-6410-4-10</ArticleId><ArticleId IdType="pmc">PMC3652739</ArticleId><ArticleId IdType="pubmed">23651648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewagama A, Patel D, Yarlagadda S, Strickland FM, Richardson BC. Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun. 2009;10(5):509–16. Epub 2009/03/13. doi: 10.1038/gene.2009.12 ; PubMed Central PMCID: PMC2735332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2009.12</ArticleId><ArticleId IdType="pmc">PMC2735332</ArticleId><ArticleId IdType="pubmed">19279650</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Cooper LT Jr., Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol. 2013;38(1):7–46. Epub 2012/11/20. doi: 10.1016/j.cpcardiol.2012.07.003 ; PubMed Central PMCID: PMC4136454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2012.07.003</ArticleId><ArticleId IdType="pmc">PMC4136454</ArticleId><ArticleId IdType="pubmed">23158412</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff JF. Viral myocarditis. A review. Am J Pathol. 1980;101(2):425–84. Epub 1980/11/01. ; PubMed Central PMCID: PMC1903609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1903609</ArticleId><ArticleId IdType="pubmed">6254364</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med. 2000;6(6):693–7. Epub 2000/06/03. doi: 10.1038/76277 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/76277</ArticleId><ArticleId IdType="pubmed">10835688</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods. 2007;41(1):118–22. doi: 10.1016/j.ymeth.2006.07.009 ; PubMed Central PMCID: PMC1764911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2006.07.009</ArticleId><ArticleId IdType="pmc">PMC1764911</ArticleId><ArticleId IdType="pubmed">17161308</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke A, Huber S, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol. 1995;69(11):6720–8. Epub 1995/11/01. doi: 10.1128/JVI.69.11.6720-6728.1995 ; PubMed Central PMCID: PMC189582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.11.6720-6728.1995</ArticleId><ArticleId IdType="pmc">PMC189582</ArticleId><ArticleId IdType="pubmed">7474082</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Kupperman J, Newell MK. Hormonal regulation of CD4(+) T-cell responses in coxsackievirus B3-induced myocarditis in mice. J Virol. 1999;73(6):4689–95. doi: 10.1128/JVI.73.6.4689-4695.1999 ; PubMed Central PMCID: PMC112510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.6.4689-4695.1999</ArticleId><ArticleId IdType="pmc">PMC112510</ArticleId><ArticleId IdType="pubmed">10233928</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Pfaeffle B. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol. 1994;68(8):5126–32. doi: 10.1128/JVI.68.8.5126-5132.1994 ; PubMed Central PMCID: PMC236456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.68.8.5126-5132.1994</ArticleId><ArticleId IdType="pmc">PMC236456</ArticleId><ArticleId IdType="pubmed">8035512</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Sartini D, Exley M. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. J Virol. 2002;76(21):10785–90. Epub 2002/10/09. doi: 10.1128/jvi.76.21.10785-10790.2002 ; PubMed Central PMCID: PMC136647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.21.10785-10790.2002</ArticleId><ArticleId IdType="pmc">PMC136647</ArticleId><ArticleId IdType="pubmed">12368321</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Moraska A, Choate M. T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis. J Virol. 1992;66(11):6541–6. Epub 1992/11/01. doi: 10.1128/JVI.66.11.6541-6546.1992 ; PubMed Central PMCID: PMC240148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.66.11.6541-6546.1992</ArticleId><ArticleId IdType="pmc">PMC240148</ArticleId><ArticleId IdType="pubmed">1328680</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S, Shi C, Budd RC. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol. 2002;76(13):6487–94. Epub 2002/06/07. doi: 10.1128/jvi.76.13.6487-6494.2002 ; PubMed Central PMCID: PMC136276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.13.6487-6494.2002</ArticleId><ArticleId IdType="pmc">PMC136276</ArticleId><ArticleId IdType="pubmed">12050361</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Stone JE, Wagner DH Jr., Kupperman J, Pfeiffer L, David C, et al.. gamma delta+ T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis. J Virol. 1999;73(7):5630–6. Epub 1999/06/11. doi: 10.1128/JVI.73.7.5630-5636.1999 ; PubMed Central PMCID: PMC112621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.7.5630-5636.1999</ArticleId><ArticleId IdType="pmc">PMC112621</ArticleId><ArticleId IdType="pubmed">10364312</ArticleId></ArticleIdList></Reference><Reference><Citation>Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol. 2001;75(5):2377–87. Epub 2001/02/13. doi: 10.1128/JVI.75.5.2377-2387.2001 ; PubMed Central PMCID: PMC114821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.5.2377-2387.2001</ArticleId><ArticleId IdType="pmc">PMC114821</ArticleId><ArticleId IdType="pubmed">11160741</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball CC, Harkins S, Whitton JL. Enumeration and functional evaluation of virus-specific CD4+ and CD8+ T cells in lymphoid and peripheral sites of coxsackievirus B3 infection. J Virol. 2008;82(9):4331–42. Epub 2008/02/29. doi: 10.1128/JVI.02639-07 ; PubMed Central PMCID: PMC2293035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02639-07</ArticleId><ArticleId IdType="pmc">PMC2293035</ArticleId><ArticleId IdType="pubmed">18305030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball CC, Harkins S, Whitmire JK, Flynn CT, Feuer R, Whitton JL. Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PLoS Pathog. 2009;5(10):e1000618. Epub 2009/10/17. doi: 10.1371/journal.ppat.1000618 ; PubMed Central PMCID: PMC2757675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000618</ArticleId><ArticleId IdType="pmc">PMC2757675</ArticleId><ArticleId IdType="pubmed">19834548</ArticleId></ArticleIdList></Reference><Reference><Citation>Abston ED, Coronado MJ, Bucek A, Bedja D, Shin J, Kim JB, et al.. Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin Dev Immunol. 2012;2012:129486. doi: 10.1155/2012/129486 ; PubMed Central PMCID: PMC3195533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/129486</ArticleId><ArticleId IdType="pmc">PMC3195533</ArticleId><ArticleId IdType="pubmed">22013485</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CM, Wang Y, Pfeiffer JK. Sex-Dependent Intestinal Replication of an Enteric Virus. J Virol. 2017;91(7). Epub 2017/01/20. doi: 10.1128/JVI.02101-16 ; PubMed Central PMCID: PMC5355612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02101-16</ArticleId><ArticleId IdType="pmc">PMC5355612</ArticleId><ArticleId IdType="pubmed">28100612</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CM, Woods Acevedo MA, McCune BT, Pfeiffer JK. Related Enteric Viruses Have Different Requirements for Host Microbiota in Mice. J Virol. 2019;93(23). Epub 2019/09/13. doi: 10.1128/JVI.01339-19 ; PubMed Central PMCID: PMC6854509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01339-19</ArticleId><ArticleId IdType="pmc">PMC6854509</ArticleId><ArticleId IdType="pubmed">31511379</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhalech AH, Corn CM, Mangale V, Syed F, Condotta SA, Richer MJ, et al.. Testosterone Promotes the Intestinal Replication and Dissemination of Coxsackievirus B3 in an Oral Inoculation Mouse Model. J Virol. 2022;96(17):e0123222. Epub 2022/08/30. doi: 10.1128/jvi.01232-22 ; PubMed Central PMCID: PMC9472648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01232-22</ArticleId><ArticleId IdType="pmc">PMC9472648</ArticleId><ArticleId IdType="pubmed">36037480</ArticleId></ArticleIdList></Reference><Reference><Citation>Slifka MK, Whitton JL. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat Immunol. 2001;2(8):711–7. doi: 10.1038/90650 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/90650</ArticleId><ArticleId IdType="pubmed">11477407</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai D, Pham NL, Harty JT, Badovinac VP. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J Immunol. 2009;183(12):7672–81. Epub 2009/11/26. doi: 10.4049/jimmunol.0902874 ; PubMed Central PMCID: PMC2808048.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902874</ArticleId><ArticleId IdType="pmc">PMC2808048</ArticleId><ArticleId IdType="pubmed">19933864</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlub TE, Badovinac VP, Sabel JT, Harty JT, Davenport MP. Predicting CD62L expression during the CD8+ T-cell response in vivo. Immunol Cell Biol. 2010;88(2):157–64. Epub 2009/10/28. doi: 10.1038/icb.2009.80 ; PubMed Central PMCID: PMC2824781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2009.80</ArticleId><ArticleId IdType="pmc">PMC2824781</ArticleId><ArticleId IdType="pubmed">19859082</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolz JC, Starbeck-Miller GR, Harty JT. Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions. Immunotherapy. 2011;3(10):1223–33. Epub 2011/10/15. doi: 10.2217/imt.11.100 ; PubMed Central PMCID: PMC3214994.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/imt.11.100</ArticleId><ArticleId IdType="pmc">PMC3214994</ArticleId><ArticleId IdType="pubmed">21995573</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott DS, Varga SM. Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think. J Immunol. 2011;187(11):5568–76. Epub 2011/11/02. doi: 10.4049/jimmunol.1102104 ; PubMed Central PMCID: PMC3221938.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102104</ArticleId><ArticleId IdType="pmc">PMC3221938</ArticleId><ArticleId IdType="pubmed">22043009</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe. 2011;9(6):451–62. Epub 2011/06/15. doi: 10.1016/j.chom.2011.05.008 ; PubMed Central PMCID: PMC3117254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.05.008</ArticleId><ArticleId IdType="pmc">PMC3117254</ArticleId><ArticleId IdType="pubmed">21669394</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler NS, Moebius J, Pewe LL, Traore B, Doumbo OK, Tygrett LT, et al.. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol. 2011;13(2):188–95. Epub 2011/12/14. doi: 10.1038/ni.2180 ; PubMed Central PMCID: PMC3262959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2180</ArticleId><ArticleId IdType="pmc">PMC3262959</ArticleId><ArticleId IdType="pubmed">22157630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura D, Miyakoda M, Kimura K, Honma K, Hara H, Yoshida H, et al.. Interleukin-27-Producing CD4(+) T Cells Regulate Protective Immunity during Malaria Parasite Infection. Immunity. 2016;44(3):672–82. Epub 2016/03/13. doi: 10.1016/j.immuni.2016.02.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.011</ArticleId><ArticleId IdType="pubmed">26968425</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardy RD, Rajah MM, Condotta SA, Taylor NG, Sagan SM, Richer MJ. Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice. PLoS Pathog. 2017;13(2):e1006184. Epub 2017/02/24. doi: 10.1371/journal.ppat.1006184 ; PubMed Central PMCID: PMC5322871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006184</ArticleId><ArticleId IdType="pmc">PMC5322871</ArticleId><ArticleId IdType="pubmed">28231312</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisancho-Kiss S, Coronado MJ, Frisancho JA, Lau VM, Rose NR, Klein SL, et al.. Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun. 2009;23(5):649–57. doi: 10.1016/j.bbi.2008.12.002 ; PubMed Central PMCID: PMC3148833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2008.12.002</ArticleId><ArticleId IdType="pmc">PMC3148833</ArticleId><ArticleId IdType="pubmed">19126426</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingersoll MA. Sex differences shape the response to infectious diseases. PLoS Pathog. 2017;13(12):e1006688. Epub 2017/12/29. doi: 10.1371/journal.ppat.1006688 ; PubMed Central PMCID: PMC5746274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006688</ArticleId><ArticleId IdType="pmc">PMC5746274</ArticleId><ArticleId IdType="pubmed">29284060</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt A, Jakel S, Textoris-Taube K, Keller C, Drung I, Szalay G, et al.. Generation of in silico predicted coxsackievirus B3-derived MHC class I epitopes by proteasomes. Amino Acids. 2010;39(1):243–55. Epub 2009/12/10. doi: 10.1007/s00726-009-0434-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-009-0434-5</ArticleId><ArticleId IdType="pubmed">19997756</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakel S, Kuckelkorn U, Szalay G, Plotz M, Textoris-Taube K, Opitz E, et al.. Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis. Am J Pathol. 2009;175(2):510–8. Epub 2009/07/11. doi: 10.2353/ajpath.2009.090033 ; PubMed Central PMCID: PMC2716952.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.090033</ArticleId><ArticleId IdType="pmc">PMC2716952</ArticleId><ArticleId IdType="pubmed">19590042</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinzierl AO, Rudolf D, Maurer D, Wernet D, Rammensee HG, Stevanovic S, et al.. Identification of HLA-A*01- and HLA-A*02-restricted CD8+ T-cell epitopes shared among group B enteroviruses. J Gen Virol. 2008;89(Pt 9):2090–7. Epub 2008/08/30. doi: 10.1099/vir.0.2008/000711-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/000711-0</ArticleId><ArticleId IdType="pubmed">18753217</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela-Calvino R, Skowera A, Arif S, Peakman M. Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein. J Virol. 2004;78(24):13399–408. Epub 2004/11/27. doi: 10.1128/JVI.78.24.13399-13408.2004 ; PubMed Central PMCID: PMC533958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.24.13399-13408.2004</ArticleId><ArticleId IdType="pmc">PMC533958</ArticleId><ArticleId IdType="pubmed">15564450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasrado N, Gangaplara A, Arumugam R, Massilamany C, Pokal S, Zhou Y, et al.. Identification of Immunogenic Epitopes That Permit the Detection of Antigen-Specific T Cell Responses in Multiple Serotypes of Group B Coxsackievirus Infections. Viruses. 2020;12(3). Epub 2020/04/05. doi: 10.3390/v12030347 ; PubMed Central PMCID: PMC7150766.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12030347</ArticleId><ArticleId IdType="pmc">PMC7150766</ArticleId><ArticleId IdType="pubmed">32245257</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein Y, Ran S, Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J Immunol. 1984;132(2):656–61. Epub 1984/02/01. .</Citation><ArticleIdList><ArticleId IdType="pubmed">6228595</ArticleId></ArticleIdList></Reference><Reference><Citation>Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 ligands induce higher IFN-alpha production in females. J Immunol. 2006;177(4):2088–96. Epub 2006/08/05. doi: 10.4049/jimmunol.177.4.2088 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.4.2088</ArticleId><ArticleId IdType="pubmed">16887967</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006;312(5780):1669–72. Epub 2006/05/20. doi: 10.1126/science.1124978 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1124978</ArticleId><ArticleId IdType="pubmed">16709748</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, et al.. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med. 2009;15(8):955–9. Epub 2009/07/15. doi: 10.1038/nm.2004 ; PubMed Central PMCID: PMC2821111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2004</ArticleId><ArticleId IdType="pmc">PMC2821111</ArticleId><ArticleId IdType="pubmed">19597505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med. 2005;202(5):637–50. Epub 2005/09/01. doi: 10.1084/jem.20050821 ; PubMed Central PMCID: PMC2212878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050821</ArticleId><ArticleId IdType="pmc">PMC2212878</ArticleId><ArticleId IdType="pubmed">16129706</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu HC, Grusdat M, Pandyra AA, Polz R, Huang J, Sharma P, et al.. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity. 2014;40(6):949–60. Epub 2014/06/10. doi: 10.1016/j.immuni.2014.05.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.05.004</ArticleId><ArticleId IdType="pubmed">24909887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CY, Woodruff JJ, Woodruff JF. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. III. Role of sex. J Immunol. 1977;119(2):591–7. Epub 1977/08/01. PubMed PMID: 301899.</Citation><ArticleIdList><ArticleId IdType="pubmed">301899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AI, Grimes KA, Coyne CB. Enterovirus Replication and Dissemination Are Differentially Controlled by Type I and III Interferons in the Gastrointestinal Tract. mBio. 2022:e0044322. Epub 2022/05/24. doi: 10.1128/mbio.00443-22 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00443-22</ArticleId><ArticleId IdType="pmc">PMC9239134</ArticleId><ArticleId IdType="pubmed">35604122</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, Wheadon M, et al.. Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science. 2015;347(6219):266–9. doi: 10.1126/science.1258025 ; PubMed Central PMCID: PMC4409937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258025</ArticleId><ArticleId IdType="pmc">PMC4409937</ArticleId><ArticleId IdType="pubmed">25431490</ArticleId></ArticleIdList></Reference><Reference><Citation>Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, Artyomov M, et al.. Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity. Science. 2015;347(6219):269–73. doi: 10.1126/science.1258100 ; PubMed Central PMCID: PMC4398891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258100</ArticleId><ArticleId IdType="pmc">PMC4398891</ArticleId><ArticleId IdType="pubmed">25431489</ArticleId></ArticleIdList></Reference><Reference><Citation>Manivasagam S, Klein RS. Type III Interferons: Emerging Roles in Autoimmunity. Front Immunol. 2021;12:764062. Epub 20211126. doi: 10.3389/fimmu.2021.764062 ; PubMed Central PMCID: PMC8660671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.764062</ArticleId><ArticleId IdType="pmc">PMC8660671</ArticleId><ArticleId IdType="pubmed">34899712</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MV, Hopkins DC, Barr FD, Wira CR. Sex Hormones and Aging Modulate Interferon Lambda 1 Production and Signaling by Human Uterine Epithelial Cells and Fibroblasts. Front Immunol. 2021;12:718380. Epub 20210924. doi: 10.3389/fimmu.2021.718380 ; PubMed Central PMCID: PMC8497887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.718380</ArticleId><ArticleId IdType="pmc">PMC8497887</ArticleId><ArticleId IdType="pubmed">34630393</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Dienz O, Roberts B, Moussawi M, Rincon M, Huber SA. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis. Exp Mol Pathol. 2012;92(3):327–33. Epub 2012/04/03. doi: 10.1016/j.yexmp.2012.03.009 ; PubMed Central PMCID: PMC3354021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2012.03.009</ArticleId><ArticleId IdType="pmc">PMC3354021</ArticleId><ArticleId IdType="pubmed">22465422</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol. 2005;174(8):4465–9. Epub 2005/04/09. doi: 10.4049/jimmunol.174.8.4465 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.8.4465</ArticleId><ArticleId IdType="pubmed">15814665</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee Mon KJ, Goldsmith E, Watson NB, Wang J, Smith NL, Rudd BD. Differential Sensitivity to IL-12 Drives Sex-Specific Differences in the CD8+ T Cell Response to Infection. Immunohorizons. 2019;3(4):121–32. Epub 2019/07/19. doi: 10.4049/immunohorizons.1800066 ; PubMed Central PMCID: PMC6636834.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.1800066</ArticleId><ArticleId IdType="pmc">PMC6636834</ArticleId><ArticleId IdType="pubmed">31317126</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsa R, London M, Rezende de Castro TB, Reis B, Buissant des Amorie J, Smith JG, et al.. Newly recruited intraepithelial Ly6A(+)CCR9(+)CD4(+) T cells protect against enteric viral infection. Immunity. 2022. Epub 2022/05/27. doi: 10.1016/j.immuni.2022.05.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.05.001</ArticleId><ArticleId IdType="pmc">PMC9283333</ArticleId><ArticleId IdType="pubmed">35617965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, et al.. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol. 2005;79(7):4460–9. doi: 10.1128/JVI.79.7.4460-4469.2005 ; PubMed Central PMCID: PMC1061561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.7.4460-4469.2005</ArticleId><ArticleId IdType="pmc">PMC1061561</ArticleId><ArticleId IdType="pubmed">15767446</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>